Total results with these characteristics: 56
- 10 Tips for Successful Malaria Vaccine Advocacy
Slow decision-making by policymakers can contribute to a substantial lag between the availability of lifesaving interventions, such as vaccines, and developing countries’ access to them. This booklet presents a set of advocacy tips, success …
- Analysis of World Health Organization Policy Development Processes for a New Intervention: Malaria Vaccines
This document aims to elucidate the World Health Organization (WHO) process for developing policy guidelines for a malaria vaccine. The analysis considered past WHO recommendations on new interventions and assessed potential implications …
- Apical Membrane Antigen 1: A Malaria Vaccine Candidate in Review
This article, published in Trends in Parasitology, presents the current understanding of apical membrane antigen 1 (AMA1), particularly in relation to the potential of AMA1 as a malaria vaccine and the approaches being taken toward clinical …
Author: Remarque EJ, Faber BW, Kocken CH, Thomas AW
- Artemisinin Resistance in Plasmodium falciparum Malaria
This study, published in the New England Journal of Medicine, compares the efficacies of two treatments--oral artesunate and artesunate followed by mefloquine--for uncomplicated falciparum malaria in Pailin, western Cambodia, and Wang Pha, …
Author: Dondorp AM, Nosten F, Yi P, et al.
- Breaking the Cycle With Vaccines: The Malaria Life Cycle
This graphic displays the malaria parasite's life cycle and highlights where three different types of vaccines could interrupt various stages of the life cycle.
- Can Successful Vaccines Teach Us How to Induce Efficient Protective Immune Responses?
This article, published in Nature Medicine, reviews current successful vaccines and identifies their mechanisms of protection in the hopes of tackling the challenges posed by those infectious targets that have thus far escaped successful …
Author: Lambert PH, Liu M, Siegrist CA
- A Chemiluminescent-Western Blot Assay for Quantitative Detection of Plasmodium falciparum Circumsporozoite Protein
Highly sensitive and reliable assays based on the quantitation of immunologically relevant component(s) in recombinant or whole parasite-based vaccines would facilitate pre-clinical and clinical phases and the monitoring of malaria vaccine …
Author: Kumar S, Zheng H, Sangweme DT, et al.
- Clinical Trials: Steps in Malaria Vaccine Development
This fact sheet provides an overview of the development and testing of malaria vaccine candidates through clinical trials, including an explanation of why trials are important and descriptions of each clinical trial phase.
- Community Perceptions of Malaria and Vaccines in the South Coast and Busia Regions of Kenya
Malaria is a leading cause of morbidity and mortality in children younger than 5 years in Kenya. Within the context of planning for a vaccine to be used alongside existing malaria control methods, this study, published in Malaria …
Author: Ba-Nguz A, Bingham A, Collymore Y, et al.
- Community Perceptions of Malaria and Vaccines in Two Districts of Mozambique
Malaria is a leading cause of mortality and morbidity in Mozambique, with nearly three-quarters of the country’s malaria-related deaths occurring in children younger than five years. A malaria vaccine is not yet available, but planning is …
Author: Bingham A, Gaspar F, Lancaster K, Conjera J, Collymore Y, Ba-Nguz A
- Disease Outbreak News
This web page provides frequently updated information about current disease outbreaks, as well as disease-specific archives of past alerts and links to related resources.
Author: World Health Organization
- Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine During 18 Months After Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
This article, published in PLoS Medicine, reports on follow-up data from a Phase 3 trial conducted to test the effectiveness of the malaria vaccine candidate RTS,S/AS01 in children and young infants. RTS,S/AS01 prevented many cases of clinical and …
Author: RTS,S Clinical Trials Partnership
- Efficacy of RTS,S/AS01E Vaccine Against Malaria in Children 5 to 17 Months of Age
This study, published in the New England Journal of Medicine, evaluated the efficacy of the RTS,S malaria vaccine given with a more immunogenic adjuvant system (AS01E) than one used in a previous study (AS02A). The study was conducted in …
Author: Bejon P, Lusingu J, Olotu A, et al.
- Fighting Malaria Today and Tomorrow
This fact sheet describes PATH's work in malaria control and prevention, including its work under the Malaria Control and Evaluation Partnership in Africa and the PATH Malaria Vaccine Initiative.
- First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
A malaria vaccine, deployed in combination with current malaria-control tools, could play an important role in future control and eventual elimination of malaria in Africa. This article, published in the New England Journal of Medicine (NEJM), …
Author: The RTS,S Clinical Trials Partnership
- From Pipeline to Product: Malaria R&D Funding Needs Into the Next Decade
This report serves as a tool to guide policymakers’ investment in new tools to control malaria, contain emerging threats, and move toward the goal of eradicating malaria from the world. It looks at the estimated funding needed for Research & …
- The Global Malaria Action Plan for a Malaria-Free World
The Global Malaria Action Plan is a framework for action that presents (i) a comprehensive overview of the global malaria landscape, (ii) an evidence-based approach to deliver effective prevention and treatment to all people at risk, and …
Author: Roll Back Malaria Partnership
- A Hopeful Beginning for Malaria Vaccines
This editorial, published in the New England Journal of Medicine, discusses the RTS,S vaccine against malaria and the significance of this being the first malaria vaccine to reach an advanced stage of development.
Author: Collins WE, Barnwell JW
- Increasing Access to Lifesaving Vaccines: PATH Closes the Immunization Gap Through Innovation and Collaboration
This fact sheet outlines PATH's work on vaccines and immunization. Topic areas include developing affordable vaccines, designing innovative vaccine technologies, and expanding uptake of existing vaccines. These efforts reduce the burden of malaria, …
- Innovating to Improve Health: PATH Develops and Delivers Novel Solutions for Those Who Need Them Most
This fact sheet provides an overview of PATH's work to develop and deliver innovative health solutions for those who need them most. These solutions range from developing and introducing affordable, appropriate technologies to creating conditions …
- Introducing New Vaccines Into Developing Countries: Obstacles, Opportunities, and Complexities
This commentary, published in Nature Medicine, reviews current trends that may affect whether the most promising of the 350 vaccine candidates under development will eventually be used in programs for the poor in developing countries. It also …
Author: Clemens J, Jodar L
- Jordan Report: Accelerated Development of Vaccines 2012
This comprehensive report includes expert articles on a variety of vaccine-related topics and updates on vaccine research for specific infectious diseases, such as influenza, malaria, respiratory syncytial virus, and rotavirus.
Author: US National Institute of Allergy and Infectious Diseases
- Landscape Analysis: Trends in Vaccine Availability and Novel Vaccine Delivery Technologies: 2008–2025
This landscape analysis identifies trends in the availability of vaccines and novel vaccine delivery technologies that are and will be of relevance to low- and middle-income countries from the present through 2025.
Author: PATH, World Health Organization
- Making Malaria History
Malaria is preventable and treatable, but to eliminate it requires political commitment, financial support, and a higher level of local ownership than ever before. This website is a resource for the global malaria community to provide updates on the …
This web page provides information on malaria as well as links to relevant malaria resources.
Author: World Health Organization